ParkinSong: Outcomes of a 12-Month Controlled Trial of Therapeutic Singing Groups in Parkinson's Disease.

Journal of Parkinson's Disease
Jeanette TamplinAdam P Vogel

Abstract

Parkinson's disease (PD) frequently causes progressive deterioration in speech, voice and cognitive aspects of communication. These affect wellbeing and quality of life and are associated with caregiver strain and burden. Therapeutic singing groups can ameliorate PD-related communication disorders and increase social interaction and wellbeing for caregivers and care recipients. To analyse the effects of ParkinSong group singing sessions on Parkinson's communication and wellbeing outcomes for people with PD and caregivers over 12 months. A 4-armed controlled clinical trial compared ParkinSong with active non-singing control conditions over 12 months. Two dosage levels (weekly versus monthly) were available for each condition. ParkinSong comprised high-effort vocal, respiratory and speech exercises, group singing, and social interaction. PD-specific outcomes included vocal loudness, speech intelligibility, maximum phonation time, respiratory muscle strength, and voice related quality of life (QoL). Wellbeing outcomes were also measured for caregivers and care recipients. We recruited 75 people with PD and 44 caregivers who attended weekly ParkinSong, monthly ParkinSong, weekly control or monthly control groups. We found significa...Continue Reading

References

Jan 1, 1986·Annual Review of Neuroscience·G E AlexanderP L Strick
Jul 1, 1996·Physical Therapy·M E MorrisJ J Summers
Jun 16, 2001·Journal of Speech, Language, and Hearing Research : JSLHR·E P Ma, E M Yiu
Jan 27, 2005·Journal of Behavioral Medicine·Gunter KreutzDorothee Grebe
Mar 17, 2006·Age and Ageing·Nick MillerDavid Burn
Apr 19, 2006·International Psychogeriatrics·H B Svansdottir, J Snaedal
Sep 8, 2006·NeuroImage·Elif OzdemirGottfried Schlaug
May 10, 2007·Journal of Cognitive Neuroscience·Jessica A Grahn, Matthew Brett
Aug 30, 2008·European Neurology·Masayuki Satoh, Shigeki Kuzuhara
Nov 26, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Christopher G GoetzUNKNOWN Movement Disorder Society UPDRS Revision Task Force
Dec 22, 2009·Physical Therapy·Meg E MorrisMargaret L Schenkman
Jul 14, 2012·Journal of Clinical Nursing·Siok Bee TanMeg E Morris
Oct 30, 2012·Archives of Physical Medicine and Rehabilitation·Jeanette TamplinDavid J Berlowitz
Dec 10, 2013·NeuroImage. Clinical·Christiane ArnoldChristian A Kell
Sep 10, 2014·Journal of Communication Disorders·Jenna P ClarkMandar Jog
Sep 17, 2014·Archives of Physical Medicine and Rehabilitation·Joanne ShanahanAmanda M Clifford
Jan 9, 2015·Neurorehabilitation and Neural Repair·Meg E MorrisRobert Iansek
Aug 15, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Bastiaan R BloemGeorg Ebersbach
Oct 17, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Ronald B PostumaGünther Deuschl
Dec 10, 2015·Neuroscience and Biobehavioral Reviews·Janet van UemWalter Maetzler
Mar 19, 2016·Disability and Rehabilitation·Elizabeth L StegemöllerChristine Sapienza
Jun 4, 2016·Journal of Parkinson's Disease·Jean BarnishMaxwell S Barnish
Sep 14, 2016·Brain and Language·Robert HarrisBauke M de Jong
Mar 25, 2017·Archives of Physical Medicine and Rehabilitation·Joanne ShanahanAmanda M Clifford
Jun 9, 2017·Nature Reviews. Neuroscience·Anthony H V SchapiraPeter Jenner
Jul 1, 2017·Lancet Neurology·Aleksi J SihvonenSeppo Soinila
Jul 9, 2017·Practical Neurology·Nick Miller
Nov 14, 2017·JAMA Neurology·E Ray Dorsey, Bastiaan R Bloem
May 17, 2018·The Medical Journal of Australia·Nataliya Titova, K Ray Chaudhuri
Sep 29, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Lorraine RamigKatherine Freeman
Dec 26, 2018·Journal of Parkinson's Disease·Deborah SturmElke Kalbe
Jan 7, 2019·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Hua LiuXiao-Lan Zhou
May 14, 2019·Neurorehabilitation and Neural Repair·Jeanette TamplinAdam P Vogel
Jul 26, 2019·Expert Review of Neurotherapeutics·Michelle MageeAdam P Vogel

❮ Previous
Next ❯

Citations

Nov 26, 2020·Clinical Rehabilitation·Natalia Muñoz-ViguerasIrene Torres-Sánchez

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.